In vivo decreased dopamine transporter uptake in corticobasal degeneration presenting with primary progressive aphasia without parkinsonism

Eur J Neurol. 2014 Jul;21(7):e56-7. doi: 10.1111/ene.12445.

Authors

S Gil-Navarro¹, E Gelpi, F Lomeña, N Montagut, A Lladó, J L Molinuevo, R Sánchez-Valle

Affiliation

¹ Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Department, Hospital Clínic, Barcelona, Spain.

PMID: 24919427
DOI: 10.1111/ene.12445

No abstract available

Keywords: 123I-FP-CIT SPECT; corticobasal degeneration; primary progressive aphasia; primary progressive nonfluent aphasia; tauopathy.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Atrophy / metabolism
Atrophy / pathology
Basal Ganglia / metabolism
Basal Ganglia / pathology
Cerebral Cortex / metabolism
Cerebral Cortex / pathology
Dopamine Plasma Membrane Transport Proteins / metabolism
Humans
Male
Middle Aged
Primary Progressive Nonfluent Aphasia / diagnosis*
Primary Progressive Nonfluent Aphasia / etiology
Tauopathies / complications
Tauopathies / diagnosis*

Substances

Dopamine Plasma Membrane Transport Proteins